About this trial
Hiatal hernia can present with a wide range of symptoms. An usual surgical repair technique usually includes Nissen fundoplication, while other procedures are less frequently employed. However, recurrence and reoperation rates remain high. This randomized controlled trial aims to compare the efficacy of Nissen and Dor fundoplication in preventing hiatal hernia recurrence and reducing the risk of reoperation
Participants undergoing minimally invasive hiatal hernia repair will be randomly assigned to either Nissen or Dor fundoplication. Postoperatively at 12 months, anatomical recurrence rates based on computed tomography scans and symptomatic recurrence rates, anti-reflux medication use, GERD-related quality of life, and dysphagia symptoms will be assessed. A subsequent long-term follow-up study will conducted afterwards utilizing national registry data to evaluate reoperation rates and anti-reflux medication use
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least 18 years of age
Type II-IV hiatal hernia, confirmed by radiology or endoscopy
Scheduled for mini-invasive hiatal hernia repair
Emergency mini-invasive surgery for hiatal hernia
Disqualifiers
Recurrent hiatal hernia
Need for esophageal lengthening procedure (Collis)
Gangrene or need for any resection during (emergency) surgery
Need for laparotomy or thoracotomy/thoracoscopy
Trial design
Parallel
Treatments tested in this trial
Nissen fundoplication
Procedure/SurgeryHiatal hernia repair and Nissen fundoplication
Dor fundoplication
Procedure/SurgeryHiatal hernia repair and Dor fundoplication
Treatment groups
Trial outcomes
Primary outcomes
Anatomical recurrence of hiatal hernia
Computed tomography based recurrence after Nissen versus Dor fundoplication
Symptomatic recurrence of hiatal hernia
Anatomical recurrence with questionnaire based gastroesophageal reflux disease (GERD) or dysphagia symptoms, or need for reoperation for recurrence
Secondary outcomes
Symptomatic versus asymptomatic recurrence rates
Symptomatic versus asymptomatic recurrence rates at 12 months
Reoperation rates
Reoperation rates at 3-, 5-, 10- and 20-years following the surgery
Managing GERD symptoms with Nissen vs Dor fundoplication
The efficacy of Nissen vs Dor fundoplication techniques in improving the Gastroesophageal Reflux Disease-Health Related Quality of Life instrument (GERD-HRQL) scores at 12 months. Minimum score 0 = no symptoms, maximum score 75 = worst symptoms.
Dysphagia symptoms after Nissen vs Dor fundoplication
The effect of different fundoplication techniques on dysphagia symptoms assessed by Eating Assessment Tool (EAT-10 ) at 12 months. Score range from 0 to 40 with higher scores indicating more severe dysphagia.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.